Eisaburo Sueoka Selected Research

Heterogeneous-Nuclear Ribonucleoproteins (Informatin)

11/2008	Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.
4/2008	Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
11/2006	Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma.
8/2005	Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity.
4/2005	Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
12/2004	Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
4/2003	Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
6/2002	Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eisaburo Sueoka Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 06/2002
18	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2002
6	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2021 - 03/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 04/2003
4	Carcinogenesis 01/2021 - 08/2003
4	Adenocarcinoma of Lung 06/2017 - 04/2003
4	Adenocarcinoma 09/2012 - 04/2003
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
3	Leukemia 12/2018 - 01/2015
3	Adenoma (Adenomas) 02/2018 - 03/2015
2	Fatty Liver 01/2021 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2018 - 01/2015
2	Hypoxia (Hypoxemia) 01/2018 - 01/2015
2	Multiple Sclerosis 04/2008 - 12/2004
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 04/2008 - 12/2004
1	Disease Progression 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Glioma (Gliomas) 05/2019
1	Colorectal Neoplasms (Colorectal Cancer) 05/2019
1	Bronchiolitis Obliterans Syndrome 03/2019
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Neutropenia 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Experimental Melanoma 02/2018
1	Exanthema (Rash) 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Lymphadenopathy 01/2017
1	Anemia 01/2016
1	Thymoma (Thymic Carcinoma) 01/2016
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2015
1	Pulmonary Alveolar Proteinosis 12/2014
1	Rare Diseases (Rare Disease) 12/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2014
1	Back Pain (Backache) 12/2014

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
9	Tyrosine Kinase InhibitorsIBA 06/2017 - 02/2007
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2005
8	Messenger RNA (mRNA)IBA 02/2018 - 06/2002
8	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 11/2008 - 06/2002
6	TeaIBA 02/2018 - 06/2002
6	hnRNP A2IBA 11/2008 - 06/2002
5	ErbB Receptors (EGF Receptor)IBA 06/2017 - 06/2008
5	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2008 - 04/2003
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 02/2018 - 06/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2002
3	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021 - 01/2017
3	CarcinogensIBA 01/2021 - 10/2013
3	Okadaic AcidIBA 12/2018 - 10/2013
3	AntibodiesIBA 04/2008 - 09/2004
2	Cell-Free Nucleic AcidsIBA 01/2020 - 04/2005
2	mogamulizumabIBA 02/2019 - 01/2018
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 12/2018 - 10/2013
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2017 - 01/2012
2	TabletsIBA 09/2015 - 03/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2011 - 08/2011
2	RNA (Ribonucleic Acid)IBA 11/2008 - 04/2005
2	Gefitinib (Iressa)FDA Link 06/2008 - 02/2007
1	Heme (Haem)IBA 01/2022
1	ImmunosorbentsIBA 01/2021
1	Cell Adhesion Molecule-1IBA 01/2021
1	NucleolinIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Conditioned Culture MediaIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2019
1	LigandsIBA 05/2019
1	TankyrasesIBA 05/2019
1	Anticarcinogenic AgentsIBA 12/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2018
1	antineoplaston A10 (A 10)IBA 02/2018
1	Histones (Histone)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	9,10-Dimethyl-1,2-benzanthraceneIBA 12/2017
1	Discoidin Domain ReceptorsIBA 01/2017
1	Discoidin Domain Receptor 2IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2016
1	hydroxyethyl methacrylate (HEMA)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2015
1	LipidsIBA 01/2015
1	CholesterolIBA 01/2015
1	nilotinib FDA Link 12/2014
1	Imatinib Mesylate (Gleevec)FDA Link 12/2014
1	Dasatinib (BMS 354825)FDA Link 12/2014
1	Periodic AcidIBA 12/2014
1	Cadherins (E-Cadherin)IBA 01/2014
1	VimentinIBA 01/2014

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 09/2007
3	Hematopoietic Stem Cell Transplantation 03/2019 - 12/2015
3	Therapeutics 01/2017 - 09/2004
1	Precision Medicine 05/2019
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Intraperitoneal Injections 01/2015